HUBUNGAN ANTARA MATRIX METALLOPROTEINASE-13 DAN TISSUE INHIBITOR METALLOPROTEINASE-1 PADA PASIEN PERIODONTITIS KRONIS

Maulidatul Husna, Nasution aini hariyani

Abstract


Introduction:  Chronic periodontitis is a multifactorial disease that causes rapid destruction of the tissues supporting the teeth and that may lead to tooth loss. Matrix metalloproteinase-13 (MMP‐13) levels have been higher in the gingival crevicular fluid of chronic periodontitis patients and tissue inhibitor of metalloproteinase-1 (TIMP‐1) is an endogenous inhibitor of MMPs implicated in inflammation.  This review purpose to discuss the relationship between matrix metalloproteinase-13 and tissue inhibitor of metalloproteinase-1 in chronic periodontitis. Review: The level of MMP-13 plays a role in the pathogenesis of chronic periodontitis. MMP-13 (collagenase-3) is the third member of the collagenase subfamily of MMPs and it is a potent gelatinolytic and collagenolytic enzyme expressed by different cell types. The activity of these MMPs is primarily controlled by tissue inhibitors, known as TIMPs, which have an N-terminal domain that is able to inhibit MMPs. Some studies showed that MMP-13 is associated with soft and hard tissue damage during the progression of chronic periodontitis. The balance between MMPs and TIMPs plays an important role in the degradation of the extracellular matrix. In healthy periodontal conditions, TIMP levels are generally higher than in unhealthy conditions, in which MMP levels exceed the level of TIMP. Conclusion: Chronic periodontitis is characterized by the increase of MMP-13 expression during the progression of the disease, the active sites show a decrease of TIMP-1 levels in association with the elevation of MMP-13.

 


Keywords


Chronic Periodontitis; MMP-13; TIMP-1

References


Yun Kyong Lim, So Young Yoo, Young Yoon Jang, Byoung Cheon Lee, Dae Sung Lee, Joong-Ki Kook: Anti-inflammatory and in vitro bone formation effects of Garcinia mangostana L. and propolis extracts. Food Sci Biotechnologi, 2019. Vol 2, No.3: 22-28.

Mays S. Shakir, Fouad Hussain Al-Bayaty, Osama B Albajalan: Preparation and Characterization of Periodontal Chips from Egg Shell Membrane, Journal of International Dental and Medical Research, 2019, Volume 12, Number 2: Page 434.

Angel Fenol, Maya Rajan Peter, Jayachandran Perayil, Rajesh Vyloppillil, and Anuradha Bhaskar: Comparison of Salivary TIMP-1 Levels in Periodontally Involved and Healthy Controls and the Response to Nonsurgical Periodontal Therapy. International Journal of Chronic Diseases,2014, Volume 2014: 7.

Se-Jin Sung, Kyung-Min Kang, Kyung-Hyun Lee, So-Young Yoo, Joong-Ki Kook, Dae Sung Lee, and Sang-Joun Yu: Effect of Garcinia mangostana L. and propolis extracts on the inhibition of inflammation and alveolar bone loss in ligature-induced periodontitis in rats. Int J Oral Biol, june 2019,Vol. 44, No. 2: 55-61.

Herna´ndez Rı´os M, Sorsa T, Obrego ´n F, Tervahartiala T, Valenzuela MA, Pozo P, Dutzan N, Lesaffre E, Molas M, Gamonal J: Proteolytic roles of matrix metalloproteinases (MMP)-13 during progression of chronic periodontitis: initial evidence for MMP-13/MMP-9 activation cascade. J Clin Periodontol, 2009, 36:1011–1017.

Cavalla Franco, Hernández-Rios Patricia, Sorsa Timo, Biguetti Claudia and Hernández Marcela: Matrix Metalloproteinases as Regulators of Periodontal Inflammation. Int. J. Mol. Sci, 2017, 18:440.

T. Dietrich, P. Ower, M. Tank, N. X. West, C. Walter, I. Needleman, F. J. Hughes, R. Wadia, M. R. Milward, P. J. Hodge, I. L. C. Chapple, British Dental Journal, January 11 2019, volume 226 no. 1. Halaman 16-22.

J Highfield: Diagnosis and classification of periodontal disease, Australian Dental Journal, 2009, vol. 54:11–26.

Herna´ndez M, Martı´nez B, Tejerina JM, Valenzuela MA, Gamonal J: MMP-13 and TIMP-1 determinations in progressive chronic periodontitis. J Clin Periodontol, 2017, 34: 729–735.

Eunice Virtanen1, Maha Yakob2, Taina Tervahartiala1, Per‐Östen Söder, Leif C. Andersson3, Timo Sorsa, Jukka H. Meurman1, Birgitta Söder: Salivary MMP‐13 gender differences in periodontitis: A cross‐sectional study from Sweden. Clinical and Experimental Dental Research published by John Wiley & Sons Ltd, 2017,3:165–170.

Deepali D. Pawar & Dhoom S. Mehta: Effect of phase 1 periodontal therapy on gingival crevicular fluid levels of matrix metalloproteinases-3 and -13 in chronic periodontitis patients. Journal of Investigative and Clinical Dentistry, (2015), 6: 118–124

J. Verstappen and J.W. Von den Hoff: Tissue Inhibitors of Metalloproteinases (TIMPs): Their Biological Functions and Involvement in Oral Disease. J Dent Res, 2016, 85:1074-1084.

Roberto Gonçalves Junior1, Aristides da Rosa Pinheiro2,3, José Jorge Schoichet3, Carlos Henrique Ramirez Nunes3, Rackel Gonçalves3, Leticia Ladeira Bonato: MMP-13, TIMP 2 and TGFB 3 gene polymorphisms in brazilian subjects with chronic periodontitis and periimplantitis. Brazilian Dental Journal, 2016, 27(2): 128-134.

L Kardes¸ ler1, B Bıyıkog˘ lu1, S¸ C ¸ etinkalp2, M Pitkala3, T Sorsa3, N Buduneli1: Crevicular fluid matrix metalloproteinase-8, -13, and TIMP-1 levels in type 2 diabetics. Oral Diseases, 2010 16: 476–481.

Pallavi S. Ghodpage a, Rajashri A. Kolte a, Abhay P. Kolte a,Madhur Gupta: Influence of phase I periodontal therapy on levels of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1. The Saudi Dental Journal 2014, 26: 171–175.




DOI: https://doi.org/10.33854/jbd.v8i2.893

DOI (PDF (Bahasa Indonesia)): https://doi.org/10.33854/jbd.v8i2.893.g346

Refbacks

  • There are currently no refbacks.


Copyright (c) 2021 B-Dent: Jurnal Kedokteran Gigi Universitas Baiturrahmah

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.